SavedAdd your journal

Journals / Türk Fizyoterapi ve Rehabilitasyon / 2013 / Cilt: 24 - Sayı: 3

COMPARISON OF PAIN FEATURES AND THE FACTORS THAT AFFECTS QUALITY OF LIFE OF CENTRAL AND PERIPHERIC NEUROPATHIC PAIN

SANTRAL VE PERİFERİK NÖROPATİK AĞRIDA AĞRI ÖZELLİKLERİ VE YAŞAM KALİTESİNİ ETKİLEYEN FAKTÖRLERİN KARŞILAŞTIRILMASI

Muhammed KILINÇ
Ayşe LİVANELİOĞLU
Sibel YILDIRIM AKSU
Pages
169–176
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The increase of age has negative effects on the physical activity in PNP groupand energy level, emotional reactions, social isolation, physical activity and total quality oflife level in CNP group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study, was to analyse the features of pain, QoL and the effects ofage, gender and pain duration in patients with central neuropathic pain (CNP) and peripheralneuropathic pain (PNP).
📊
Key Findings & Data:Results: The mean age of patients with PNP were 51.75±18.23, and CNP were 48.5±18.74years.
💡
Conclusion & Impact:The increase of age has negative effects on the physical activity in PNP groupand energy level, emotional reactions, social isolation, physical activity and total quality oflife level in CNP group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The aim of this study, was to analyse the features of pain, QoL and the effects ofage, gender and pain duration in patients with central neuropathic pain (CNP) and peripheralneuropathic pain (PNP). Methods: Fourty patients were included in the study. The charactheristics and detailed painhistory of patients were recorded. Visual analog scale (VAS) was used to evaluate pain inten- sity and nottingham health profile (NHP) was used to evaluate QoL of patients. Results: The mean age of patients with PNP were 51.75±18.23, and CNP were 48.5±18.74years. There were no significance differences between the two group according to NSP andVAS results. The increase of age has negative effects on the physical activity in PNP groupand energy level, emotional reactions, social isolation, physical activity and total quality oflife level in CNP group (p

Özet

Amaç: Bu çalışma Santral Nöropatik Ağrı (SNA) ve Periferik Nöropatik Ağrılı (PNA) hastalarda; ağrı özellikleri ve yaşam kalitesinin incelenmesi ve yaş, ağrı süresi ve cinsiyetin yaşamkalitesi üzerine etkisinin araştırılması amacıyla planlandı. Yöntem: Çalışmaya SNA ve PNA tanıları ile izlenen 40 hasta dâhil edildi. Hastaların demografik özellikleri kaydedildi ve ağrı ile ilgili detaylı hikâyeleri alındı. Hastaların ağrı şiddetleriGörsel Analog Skalası (GAS) ile yaşam kaliteleri ise Nottingham Sağlık Profili (NSP) ile değerlendirildi. Sonuçlar: PNAlı hastaların yaş ortalaması 51.75±18.23, SNAlı hastaların ise 48.5±18.74 yılolarak bulundu. Sonuçlar incelendiğinde NSP alt parametreleri ve toplam puanı ile ağrı şiddetinin gruplar arasında farklılık göstermediği bulundu. PNA grubunda hastaların yaşı ilerledikçeyaşam kalitesinde fiziksel aktivite seviyelerinin, SNA grubunda ise enerji seviyesi, emosyonelreaksiyonlar, sosyal izolasyon, fiziksel aktivite ve toplam yaşam kalitesi seviyelerinin azaldığıbulundu (p

🔖

Cite This Article

KILINÇ, M., LİVANELİOĞLU, A., AKSU, S. Y. (2022). COMPARISON OF PAIN FEATURES AND THE FACTORS THAT AFFECTS QUALITY OF LIFE OF CENTRAL AND PERIPHERIC NEUROPATHIC PAIN. Türk Fizyoterapi ve Rehabilitasyon, Cilt: 24 - Sayı: 3, 169–176. https://ajindex.com/articles/623431

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Gustorff B, Dorner T, Likar R, et al. Prevelance of self reported neuropathic pain and impact on quality of life: A prospective representative survey. Acta Anaesthesiol Scand. 2008;52(1):132- 136
  2. Rasmussen PV, Sindrup SH, Jensen TH, et al. Symptoms and signs in patients with suspected neuropathic pain. Pain. 2004;110(1- 2):461-469
  3. Nicholson B. Gabapentin use in neuropathic pain syndromes. Acta Neurol Scand. 2000;5(4):245-252
  4. Hansson P, Lacerenza M, Marchettini P. Neuropathic pain: Pathophysiology and treatment. Seattle: IASP pres;2001:1-18
  5. Yücel A, Çimen A. Nöropatik ağrı: Mekanizmalar, tanı ve tedavi. Ağrı. 2005;17:5-13
  6. Baron R. Peripheral neuropathic pain: from mechanism to symptoms. Clin J Pain. 2000;16(2):12-20
  7. Berker E. Nöropatik ağrı etyopatogenezi. J Int Med Sci. 2005;1(10):37-40
  8. Khedr EM, Kamel NF, Ahmed MA, et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry. 2005;76(6):833-838
  9. Tan E. Nöropatik ağrı ve tedavisi. TJN. 2004;10:390-399
  10. Karlı N. Nöropatik ağrı semptomları. In: Tan E, eds. Nöropatik ağrı. Ankara: Nobel yayıncılık;2009:87-90
  11. Schmader KE. Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002;18(6):350–354
  12. Breivik H, Borchgrevink PC, Allen SM, et al. Assessment of pain. Br J Anaesth. 2008;101(1):17-24
  13. Selçuki D. Nöropatik Ağrı skalaları ile klinik değerlendirme. In: Tan E, eds. Nöropatik ağrı. Ankara: Nobel Yayıncılık;2009:99-108
  14. Kücükdeveci AA, McKenna SP, Kutlay S, et al. The development and psychometric assessment of the Turkish version of the Not- tingham Health Profile. Int J Rehabil Res. 2000;23(8):31-38
  15. Rosberg KM, Burckhardt CM, Huizar K, et al. A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. Eur J Pain. 2001;5(4):391-403
  16. Hurley RW, Adams MC, Benzon HT. Neuropathic pain: treatment guidelines and updates. Curr Opin Anaesthesiol. 2013; DOI: 10.1097/ACO.0b013e328363b4bf
  17. Ciaramitaro P, Mondelli M, Logullo F, et al. Traumatic peripheral nevre injuries: epidemiological findings, neuropathic pain and quality of life in 158 patients. J Peripher Nerv Syst. 2010;15(2):120- 127
  18. Rosberg KM, Kvarnström A, Kinnman E, et al. Peripheral neuropathic pain: a multidimensional burden for patients. Eur J Pain. 2001;5(4):379-389